Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
29
CNMD Quote, Financials, Valuation and Earnings
Last price:
$49.23
Seasonality move
:
0.65%
Day range:
$48.52 - $50.19
52-week range:
$46.00 - $78.19
Dividend yield:
1.6%
P/E ratio:
13.14x
P/S ratio:
1.18x
P/B ratio:
1.58x
Volume:
713.8K
Avg. volume:
407.7K
1-year change:
-32.09%
Market cap:
$1.5B
Revenue:
$1.3B
EPS (TTM):
$3.80
Earnings Data
Next earnings date for CNMD
Jul 30
2025
Most recent earnings per share
$0.19
Missed by $0.62
(Apr 30/2025)
Consensus Estimate
$0.81
(Apr 30/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
CNMD Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | $334.6M | -- | -- | $0.99 | -- |
| 07/30/2025 | Q2 | $338.4M | -- | -- | $1.12 | -- |
| 04/30/2025 | Q1 | $313.4M | $321.3M | $0.19 | $0.81 | -$0.62 |
| 02/05/2025 | Q4 | $341M | $345.9M | $1.08 | $1.20 | -$0.12 |
| 10/30/2024 | Q3 | $317.7M | $316.7M | $1.57 | $1.00 | $0.57 |
| 07/31/2024 | Q2 | $334.4M | $332.1M | $0.96 | $0.91 | $0.05 |
| 04/24/2024 | Q1 | $306.7M | $312.3M | $0.63 | $0.74 | -$0.11 |
| 01/31/2024 | Q4 | $332.2M | $327M | $1.05 | $1.11 | -$0.06 |
| 10/25/2023 | Q3 | $300.8M | $304.6M | $0.50 | $0.83 | -$0.33 |
| 07/26/2023 | Q2 | $306.1M | $317.7M | $0.43 | $0.79 | -$0.36 |
| 04/26/2023 | Q1 | -- | $295.5M | $0.06 | -- | -- |
| 02/02/2023 | Q4 | -- | $250.9M | $0.86 | -- | -- |
| 10/26/2022 | Q3 | -- | $275.1M | $1.48 | -- | -- |
| 07/27/2022 | Q2 | -- | $277.2M | -$5.65 | -- | -- |
| 05/04/2022 | Q1 | -- | $242.3M | $0.47 | -- | -- |
| 01/26/2022 | Q4 | -- | $274M | $0.75 | -- | -- |
| 10/27/2021 | Q3 | -- | $248.8M | $0.47 | -- | -- |
| 07/28/2021 | Q2 | -- | $255.2M | $0.41 | -- | -- |
| 04/28/2021 | Q1 | -- | $232.7M | $0.31 | -- | -- |
| 01/27/2021 | Q4 | -- | $252.8M | $0.81 | -- | -- |
| 10/28/2020 | Q3 | -- | $237.8M | $0.23 | -- | -- |
| 07/29/2020 | Q2 | -- | $157.8M | -$0.96 | -- | -- |
| 04/29/2020 | Q1 | -- | $214M | $0.20 | -- | -- |
| 01/29/2020 | Q4 | -- | $264.9M | $0.49 | -- | -- |
| 10/30/2019 | Q3 | -- | $233.6M | $0.23 | -- | -- |
| 07/31/2019 | Q2 | -- | $238.3M | $0.19 | -- | -- |
| 04/24/2019 | Q1 | -- | $218.4M | $0.04 | -- | -- |
| 01/22/2019 | Q4 | -- | $242.4M | $0.54 | -- | -- |
| 11/01/2018 | Q3 | -- | $202.3M | $0.20 | -- | -- |
| 08/01/2018 | Q2 | -- | $212.8M | $0.30 | -- | -- |
| 04/25/2018 | Q1 | -- | $202.1M | $0.37 | -- | -- |
| 01/31/2018 | Q4 | -- | $222.6M | $1.65 | -- | -- |
| 11/02/2017 | Q3 | -- | $190.1M | $0.26 | -- | -- |
| 07/26/2017 | Q2 | -- | $197.2M | $0.22 | -- | -- |
| 04/26/2017 | Q1 | -- | $186.6M | -$0.16 | -- | -- |
| 02/01/2017 | Q4 | -- | $204.1M | $0.24 | -- | -- |
| 10/27/2016 | Q3 | -- | $184.8M | $0.26 | -- | -- |
| 07/27/2016 | Q2 | -- | $193.4M | $0.10 | -- | -- |
| 04/27/2016 | Q1 | -- | $181.2M | -$0.08 | -- | -- |
| 01/27/2016 | Q4 | -- | $191M | $0.28 | -- | -- |
| 10/21/2015 | Q3 | -- | $169.2M | $0.32 | -- | -- |
Conmed Earnings Questions
-
How Much did Conmed Generate in Revenue Last Quarter?
Conmed reported $321.3M worth of top line sales in its most recent quarter.
-
Did Conmed Beat Earnings Last Quarter?
Conmed announced earnings per share of $0.19 which represents a miss of analyst forecast a $0.81 per share.
-
Is Conmed Profitable?
Conmed reported $177.8M that represents $5.71 per share over the last quarter.
-
What is the Analyst Consensus for Conmed EPS Next Year?
Conmed's earnings are forecast to grow from $4.25 per share to $4.03 per share next year representing an increase of 3.42%.
-
When is Conmed's Earnings Date?
Conmed's next earnings date is July 30, 2025.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
